查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612798

心律不整監測設備市場：按設備、最終用戶分類 - 2025-2030 年全球預測

Cardiac Arrhythmia Monitoring Devices Market by Device (Electrocardiogram Monitor, Event Recorder, Holter Monitor), End-User (Ambulatory Surgical Centers, Diagnostic Centers, Homecare Settings) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年心律不整監測設備市值為87.6億美元，預計2024年將達到94.4億美元，複合年成長率為8.03%，預計到2030年將達到150.6億美元。

心律不整監測設備對於心律不整的診斷和管理至關重要，可為治療和預防策略提供見解。該領域涉及連續、即時的資料收集和分析，這對於心臟疾病的及時診斷和有效管理至關重要。由於全球心臟相關疾病的盛行率不斷上升，加上人口老化需要先進的醫療保健解決方案，對此類設備的需求不斷增加。應用包括醫院環境、門診護理中心和家庭場景，以增強傳統臨床環境以外的病患監測。典型的最終用戶包括醫療保健專業人員、心臟病診所和尋求自我監測的技術力的患者。

主要市場統計
基準年[2023] 87.6億美元
預測年份 [2024] 94.4億美元
預測年份 [2030] 150.6億美元
複合年成長率（%） 8.03%

市場成長的推動因素包括穿戴式和無線設備等技術進步、預防性醫療保健意識的提高以及政府鼓勵數位醫療保健解決方案的支持措施。與人工智慧和機器學習的連接和整合進行預測分析為提高診斷準確性和個人化患者照護提供了重要機會。為了利用這些趨勢，鼓勵公司投資開發方便用戶使用的介面和資料隱私的安全系統。然而，挑戰包括高昂的設備成本、嚴格的法律規範和有限的報銷方案，阻礙了廣泛採用。

最大限度地發揮成長潛力需要專注於提高設備精度、延長電池壽命和小型化以提高患者舒適度和依從性的創新。解決這些技術障礙可以為市場採用提供巨大動力。此外，與高科技公司和研究機構的策略聯盟可以加快新設備的開發和核准過程。總體而言，心律不整監測設備市場仍然充滿活力，需要持續創新，以在監管和經濟挑戰的背景下抓住新機遇，幫助企業保持競爭力，並且必須能夠跟上技術進步的步伐。

市場動態：快速發展的心律不整監測設備市場的關鍵市場洞察

心律不整監測設備市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球心血管疾病盛行率不斷上升
    • 越來越關注遠端監控和遠端醫療
    • 消費者擴大採用穿戴式健康技術
  • 市場限制因素
    • 開發心律不整監測設備成本高昂
  • 市場機會
    • 心律不整監測設備的進展
    • 心血管疾病治療的政府報銷計劃和政策
  • 市場挑戰
    • 心律不整監測設備的限制與故障問題

波特五力：駕馭心律不整監測設備市場的策略工具

波特的五力架構是了解心律不整監測設備市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解心律不整監測設備市場的外部影響

外部宏觀環境因素在塑造心律不整監測設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解心律不整監測設備市場的競爭格局

心律不整監測設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣心律不整監測設備市場供應商的績效評估

FPNV定位矩陣是評估心律不整監測設備市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃心律不整監測設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對心律不整監測設備市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球心血管疾病盛行率增加
      • 人們對遠距監控和遠端醫療的興趣日益濃厚
      • 消費者擴大採用穿戴式健康技術
    • 抑制因素
      • 心律不整監測設備研發成本高
    • 機會
      • 心律不整監測設備的進展
      • 心血管疾病治療的政府報銷計劃和政策
    • 任務
      • 心律不整監測設備的限制與故障問題
  • 市場區隔分析
    • 設備：擴大採用心電圖監視器來檢測心動週期每個階段的持續時間和時間
    • 最終用戶：在優先考慮高精度設備的診斷中心中增加使用心律不整監測設備
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章心律不整監測設備市場：依設備分類

  • 心電圖監視器
  • 事件記錄器
  • 心電圖監測
  • 植入式心臟監測儀
  • 移動心電遙測

第7章心律不整監測設備市場：依最終使用者分類

  • 門診手術中心
  • 診斷中心
  • 家庭護理設置
  • 醫院/診所

第8章美洲心律不整監測設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太心律不整監測設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲心律不整監測設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • FDA核准下一代人工智慧心電圖監測設備
    • FDA核准用於長期心律不整監測的下一代可插入裝置
    • UltraLinQ 在阿拉伯健康中心推出新型心臟監測產品
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • ACS Diagnostics, Inc.
  • AliveCor, Inc.
  • Aspel SA
  • BIOTRONIK SE & CO., KG
  • BORSAM Biomedical Instruments Co., Ltd.
  • Boston Scientific Corporation
  • custo med GmbH
  • GE HealthCare Technologies, Inc.
  • Hillrom Services, Inc. by Baxter International Inc.
  • InfoBionic
  • iRhythm Technologies, Inc.
  • Koninklijke Philips NV
  • Lepu Medical Technology（Beijing）Co.,Ltd.
  • Medtronic PLC
  • Nihon Kohden Corporation
  • Norav Medical Inc.
  • OSI Systems, Inc.
  • SCHILLER
  • SmartCardia SA
  • Stryker Corporation
  • UltraLinQ Healthcare Solutions, Inc.
  • Viatom Technology Co., Ltd.
  • ZOLL Medical Corporation by Asahi Kasei Corporation
Product Code: MRR-450A0628CC43

The Cardiac Arrhythmia Monitoring Devices Market was valued at USD 8.76 billion in 2023, expected to reach USD 9.44 billion in 2024, and is projected to grow at a CAGR of 8.03%, to USD 15.06 billion by 2030.

Cardiac arrhythmia monitoring devices are critical in diagnosing and managing irregular heartbeats, offering insights for treatment and prevention strategies. The scope involves continuous and real-time data capture and analysis, crucial for timely diagnosis and effective management of cardiac conditions. There is a necessity for such devices given the rising prevalence of heart-related ailments globally, coupled with an aging population that demands advanced healthcare solutions. Applications include hospital settings, ambulatory care centers, and home-use scenarios, enhancing patient monitoring outside traditional clinical environments. Key end-users span healthcare professionals, cardiology clinics, and technologically-enabled patients aiming for self-monitoring.

KEY MARKET STATISTICS
Base Year [2023] USD 8.76 billion
Estimated Year [2024] USD 9.44 billion
Forecast Year [2030] USD 15.06 billion
CAGR (%) 8.03%

Market growth is driven by technological advancements, like wearable and wireless devices, increasing awareness of preventive healthcare, and supportive government initiatives that encourage digital healthcare solutions. Connectivity and integration with AI and machine learning for predictive analytics present significant opportunities, as they enhance diagnostic accuracy and personalized patient care. To capitalize on these trends, businesses are advised to invest in the development of user-friendly interfaces and secure systems for data privacy. However, challenging factors include high device costs, stringent regulatory frameworks, and limited reimbursement scenarios that hinder widespread adoption.

For maximum growth potential, innovation must focus on enhancing device accuracy, extending battery life, and improving miniaturization to increase patient comfort and compliance. Addressing these technological hurdles can spur market adoption significantly. Furthermore, strategic collaborations with tech companies and research institutions could accelerate the development and approval processes of new devices. Overall, the cardiac arrhythmia monitoring device market remains dynamic, with continuous innovation necessary for capturing emerging opportunities against a backdrop of regulatory and economic challenges, ensuring companies stay competitive and aligned with healthcare advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Arrhythmia Monitoring Devices Market

The Cardiac Arrhythmia Monitoring Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of cardiovascular disorders worldwide
    • Growing inclination towards remote monitoring and telemedicine
    • Rising adoption of wearable health technologies by consumers
  • Market Restraints
    • High cost of development of cardiac arrhythmia monitoring devices
  • Market Opportunities
    • Advancements in cardiac arrhythmia monitoring devices
    • Government reimbursement programs and policies for cardiovascular disease treatment
  • Market Challenges
    • Limitation and malfunctioning issues with cardiac arrhythmia monitoring devices

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Arrhythmia Monitoring Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Arrhythmia Monitoring Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Arrhythmia Monitoring Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Arrhythmia Monitoring Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Arrhythmia Monitoring Devices Market

A detailed market share analysis in the Cardiac Arrhythmia Monitoring Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Arrhythmia Monitoring Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Arrhythmia Monitoring Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Arrhythmia Monitoring Devices Market

A strategic analysis of the Cardiac Arrhythmia Monitoring Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Arrhythmia Monitoring Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, Inc., AliveCor, Inc., Aspel SA, BIOTRONIK SE & CO., KG, BORSAM Biomedical Instruments Co., Ltd., Boston Scientific Corporation, custo med GmbH, GE HealthCare Technologies, Inc., Hillrom Services, Inc. by Baxter International Inc., InfoBionic, iRhythm Technologies, Inc., Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic PLC, Nihon Kohden Corporation, Norav Medical Inc., OSI Systems, Inc., SCHILLER, SmartCardia SA, Stryker Corporation, UltraLinQ Healthcare Solutions, Inc., Viatom Technology Co., Ltd., and ZOLL Medical Corporation by Asahi Kasei Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Arrhythmia Monitoring Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device, market is studied across Electrocardiogram Monitor, Event Recorder, Holter Monitor, Implantable Cardiac Monitor, and Mobile Cardiac Telemetry.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, Homecare Settings, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cardiovascular disorders worldwide
      • 5.1.1.2. Growing inclination towards remote monitoring and telemedicine
      • 5.1.1.3. Rising adoption of wearable health technologies by consumers
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development of cardiac arrhythmia monitoring devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in cardiac arrhythmia monitoring devices
      • 5.1.3.2. Government reimbursement programs and policies for cardiovascular disease treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Limitation and malfunctioning issues with cardiac arrhythmia monitoring devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device: Growing adoption of electrocardiogram monitors for detecting the duration and timing of each phase in the heart's cycle
    • 5.2.2. End-User: Growing usage of cardiac arrhythmia monitoring devices across diagnostic centers that prioritize high-precision devices
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac Arrhythmia Monitoring Devices Market, by Device

  • 6.1. Introduction
  • 6.2. Electrocardiogram Monitor
  • 6.3. Event Recorder
  • 6.4. Holter Monitor
  • 6.5. Implantable Cardiac Monitor
  • 6.6. Mobile Cardiac Telemetry

7. Cardiac Arrhythmia Monitoring Devices Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Diagnostic Centers
  • 7.4. Homecare Settings
  • 7.5. Hospitals & Clinics

8. Americas Cardiac Arrhythmia Monitoring Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cardiac Arrhythmia Monitoring Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. FDA clears next-generation AI-powered ECG monitoring device
    • 11.3.2. FDA clears next-generation insertable device for long-term arrhythmia monitoring
    • 11.3.3. UltraLinQ to launch new cardiac monitoring product at Arab Health
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACS Diagnostics, Inc.
  • 3. AliveCor, Inc.
  • 4. Aspel SA
  • 5. BIOTRONIK SE & CO., KG
  • 6. BORSAM Biomedical Instruments Co., Ltd.
  • 7. Boston Scientific Corporation
  • 8. custo med GmbH
  • 9. GE HealthCare Technologies, Inc.
  • 10. Hillrom Services, Inc. by Baxter International Inc.
  • 11. InfoBionic
  • 12. iRhythm Technologies, Inc.
  • 13. Koninklijke Philips N.V.
  • 14. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 15. Medtronic PLC
  • 16. Nihon Kohden Corporation
  • 17. Norav Medical Inc.
  • 18. OSI Systems, Inc.
  • 19. SCHILLER
  • 20. SmartCardia SA
  • 21. Stryker Corporation
  • 22. UltraLinQ Healthcare Solutions, Inc.
  • 23. Viatom Technology Co., Ltd.
  • 24. ZOLL Medical Corporation by Asahi Kasei Corporation

LIST OF FIGURES

  • FIGURE 1. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY ELECTROCARDIOGRAM MONITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY EVENT RECORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY HOLTER MONITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE CARDIAC MONITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY MOBILE CARDIAC TELEMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023